These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11342811)

  • 1. Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease.
    Kajander EO; Ciftcioglu N; Miller-Hjelle MA; Hjelle JT
    Curr Opin Nephrol Hypertens; 2001 May; 10(3):445-52. PubMed ID: 11342811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobacteria: an infectious cause for kidney stone formation.
    Ciftçioglu N; Björklund M; Kuorikoski K; Bergström K; Kajander EO
    Kidney Int; 1999 Nov; 56(5):1893-8. PubMed ID: 10571799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin and nanobacteria in polycystic kidney disease.
    Hjelle JT; Miller-Hjelle MA; Poxton IR; Kajander EO; Ciftcioglu N; Jones ML; Caughey RC; Brown R; Millikin PD; Darras FS
    Kidney Int; 2000 Jun; 57(6):2360-74. PubMed ID: 10844606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nanobacteria--microbiological characteristics].
    Wilk I; Martirosian G
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():60-4. PubMed ID: 15069381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nanobacteria as a cause of renal diseases and vascular calcifying pathology in renal patients ("endovascular lithiasis"].
    López-Brea M; Selgas R
    Enferm Infecc Microbiol Clin; 2000 Dec; 18(10):491-2. PubMed ID: 11197997
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of nanobacteria and their possible role in stone formation.
    Kajander EO; Ciftcioglu N; Aho K; Garcia-Cuerpo E
    Urol Res; 2003 Jun; 31(2):47-54. PubMed ID: 12669155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment nephrolithiasis rat model induced by nanobacteria and analysis of stone formation].
    Hu WG; Wang XF; Xu T; Li JX; Chen L; Yu CF; Huang XB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):433-5. PubMed ID: 20721258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of the role of nanobacteria in the formation of renal stones in experimental rats and its mechanism.
    Yang H; Cheng X; Chen Y; Zeng Z; Wang G
    Arch Med Sci Atheroscler Dis; 2024; 9():e1-e15. PubMed ID: 38434940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypothesis for anti-nanobacteria effects of gallium with observations from treating kidney disease.
    Eby GA
    Med Hypotheses; 2008 Oct; 71(4):584-90. PubMed ID: 18579317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation.
    Kajander EO; Ciftçioglu N
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8274-9. PubMed ID: 9653177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The detection of nanobacteria infection in serum of healthy Chinese people].
    Wang XJ; Liu W; Yang ZL; Wei H; Wen Y; Li YG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):492-4. PubMed ID: 15231124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method.
    Cíftçíoglu N; Miller-Hjelle MA; Hjelle JT; Kajander EO
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2077-86. PubMed ID: 12069958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobacteria linked to kidney disease.
    Dorrell S
    Mol Med Today; 1999 Sep; 5(9):373. PubMed ID: 10462747
    [No Abstract]   [Full Text] [Related]  

  • 17. Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease.
    Low RK; Stoller ML
    J Urol; 1997 Dec; 158(6):2062-4. PubMed ID: 9366312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do stones form? Is unification of theories on stone formation possible?
    Bird VY; Khan SR
    Arch Esp Urol; 2017 Jan; 70(1):12-27. PubMed ID: 28221139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Approaches to Detect "Nanobacteria" in Patients with Kidney Stones: an Infectious Cause or a Subset of Life?
    Ansari H; Akhavan Sepahi A; Akhavan Sepahi M
    Urol J; 2017 Aug; 14(5):5001-5007. PubMed ID: 28853105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.